Details for 2019210527

Up to date per 01.04.2026

Actions

Title / Product Name

VERFAHREN ZUR BEHANDLUNG VON KREBSPATIENTEN MIT FARNESYL-TRANSFERASE-INHIBITOREN

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2019210527

EP Publication Number

3640345

E-Number

1436278

Language

PCT Number

Publication Date

22.04.2020 A

06.10.2021 B1

Registration Date

06.10.2021

AT Publication Date

15.10.2021

Application Date

16.08.2016

Registration Number

Priorities

17.08.2015

201562206194 P

15.09.2015

201562218927 P

13.10.2015

201562241019 P

18.03.2016

201662310582 P

09.08.2016

201662372662 P

IPC

C12Q 1/6886 20180101AFI20210330BHEP

Maximum Duration of Protection

16.08.2036

Owner

Kura Oncology, Inc.12730 High Bluff Drive, Suite 400 San Diego, CA 92130US

Representative

Schwarz & Partner Patentanwälte GmbHWipplingerstraße 301010 WienAT

Inventor

GUALBERTO, Antonio8 Larch Road Acton, MA Massachusetts 01720US

SCHOLZ, Catherine Rose8 James Millen Road North Reading, MA Massachusetts 01864US